Weight Loss Drugs Linked to Lower Breast Cancer Risk
Recent large-scale cohort studies indicate that glucagon-like peptide-1 (GLP-1) receptor agonists, primarily used for weight management and type 2 diabetes, are associated with a reduced incidence of several obesity-related cancers. ... Read More